Holly Rimmasch Named to Modern Healthcare’s 50 Most Influential Clinical Executives List

Holly Rimmasch, Chief Clinical Officer, Senior Vice President and General Manager of Clinical Quality Analytics at Health Catalyst, has been named one of Modern Healthcare’s 50 Most Influential Clinical Executives.

Modern Healthcare’s list honors individuals in healthcare who are deemed by their peers and the senior editors of Modern Healthcare to be paving the way to better health through their executive responsibility, leadership qualities, innovation, community service and achievements inside and outside of their respective organizations.

At Health Catalyst, Rimmasch was instrumental in the creation of the company’s COVID-19 Task Force, which worked to address the significant problems hospital and health system clients were facing at the height of the pandemic.

holly rimmasch 600x0 c default

Through Rimmasch’s guidance Health Catalyst rolled out nine technology services and solutions aimed at addressing the needs of hospitals and health systems around the globe, which continue to be utilized and effective to this day.

As a result of the innovative solutions, the following healthcare organizations, among others, were able to tackle their COVID-19-related clinical, operational, and financial challenges, while achieving and sustaining high quality patient care.

  • Paso Del Norte Health Information Exchange (PHIX) and Hospital Corporation of America (HCA) improved data exchange to support safe, effective transfer of patients to alternative care sites during a COVID-19 surge.
  • Albany Med was able to deploy and integrate real-time dashboards for monitoring all COVID-19 activity, including patient testing and activity, care requirements, and supply utilization, in under 16 hours.
  • Allina Health was able to effectively track and manage COVID-19 immunization for its sizeable workforce. The organization needed to confirm the immunization status for its more than 28,000 employees, 6,000 associated and employed physicians, and its on-site contracted services. In just three weeks, Allina Health obtained comprehensive COVID-19 immunization data for more than 28,000 employees, 6,000 associated and employed physicians, and all contracted services; received confirmation of COVID-19 immunization (or accommodation) for the entire Allina Health workforce; and saw $50,000 indirect labor cost savings, the result of integrating and automating COVID-19 immunization data.

In recommending Rimmasch for this achievement, Health Catalyst CEO Dan Burton said, “Holly leads with innovative thinking and with her eye on the Quadruple Aim of improving community health. Her commitment to the sustainable improvement of hospital operations and patient care, even in the toughest of times, led to frameworks and products that can assist healthcare systems in times of emergency but also provide long-term strategies as we work to shape a better healthcare future.”

Health Catalyst is proud to celebrate Rimmasch and is grateful for her mission-driven leadership as we work to deliver massive, measurable, data-informed healthcare improvement.

“Clinician leaders have shouldered a heavy load for healthcare organizations and the country at large throughout the past few years. We are proud to recognize those leaders who have risen to the occasion and then some,” said Fawn Lopez, Publisher of Modern Healthcare.

“These 50 honorees have demonstrated leadership and innovation in a time of crisis and made a vital impact on the success of their organizations, the well-being of the healthcare workforce and the health of their patients and communities. We congratulate and thank them for their dedication to the advancement of healthcare.”

The complete list of the honorees is available at Modernhealthcare.com/awards/50-most-influential-clinical-executives-2022

Association of Medical Directors of Information Systems (AMDIS) 2022 Physician-Computer Connection Symposium

This website stores data such as cookies to enable essential site functionality, as well as marketing, personalization, and analytics. By remaining on this website you indicate your consent. For more information please visit our Privacy Policy.